About: Randomized trial of filgrastim versus chemotherapy and filgrastim mobilization of hematopoietic progenitor cells for rescue in autologous transplantation

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Randomized trial of filgrastim versus chemotherapy and filgrastim mobilization of hematopoietic progenitor cells for rescue in autologous transplantation Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 October 2001

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) مقالة علمية تنشرت ف 1 أكتوبر 2001 (ary) наукова стаття, опублікована в жовтні 2001 (uk) im Oktober 2001 veröffentlichter wissenschaftlicher Artikel (de) article scientifique publié en octobre 2001 (fr) artículu científicu espublizáu n'ochobre de 2001 (ast) scientific article published on 01 October 2001 (en)
publication date	wds:Q74541729-9280193A-A0BB-49A5-A297-89BA917B8E0B
publication date	2001-10-01 00:00:00Z (xsd:dateTime)
author name string	wds:Q74541729-058AC814-CABD-42E6-A749-33BEAFC8F8CC wds:Q74541729-07E87F9E-2563-491F-A752-3C6FFD5F50C6 wds:Q74541729-0A55CC9F-AB31-4D6A-807B-DAA558C96375 wds:Q74541729-280563B5-EFEE-44E3-9FD3-2657C1EA067A wds:Q74541729-585BA467-7EFB-4BDA-BFB0-39CB068B8EAC wds:Q74541729-6C3AEE71-80A5-49B1-9F48-80CE65B86A8E wds:Q74541729-6DC54ACB-1319-4732-A5DC-5900C0CC3B9C wds:Q74541729-7904C426-2732-47EE-8AA0-A69E9939F5ED wds:Q74541729-7E098B75-F80E-4BE1-8EE1-75AC3CA2DB6F wds:Q74541729-94AE134C-CC76-42CB-A3C1-8369787C08AB wds:Q74541729-E43322CD-B38A-4A30-85DA-1BAA35E2D503 wds:Q74541729-E79F8961-5DBD-43E0-A212-21E34EE69374
author name string	C O'Connor K B Miller C Keating D P Schenkein A Al-Olama A Klekar E Berkman J K Erban J Morelli K A Sprague R Kanteti U Narayanasami
rdfs:label	Randomized trial of filgrastim versus chemotherapy and filgrastim mobilization of hematopoietic progenitor cells for rescue in autologous transplantation (en) Randomized trial of filgrastim versus chemotherapy and filgrastim mobilization of hematopoietic progenitor cells for rescue in autologous transplantation (nl)
skos:prefLabel	Randomized trial of filgrastim versus chemotherapy and filgrastim mobilization of hematopoietic progenitor cells for rescue in autologous transplantation (en) Randomized trial of filgrastim versus chemotherapy and filgrastim mobilization of hematopoietic progenitor cells for rescue in autologous transplantation (nl)
name	Randomized trial of filgrastim versus chemotherapy and filgrastim mobilization of hematopoietic progenitor cells for rescue in autologous transplantation (en) Randomized trial of filgrastim versus chemotherapy and filgrastim mobilization of hematopoietic progenitor cells for rescue in autologous transplantation (nl)
title	wds:Q74541729-323C834C-3F6E-4A32-9F55-5996BF189898
title	Randomized trial of filgrastim versus chemotherapy and filgrastim mobilization of hematopoietic progenitor cells for rescue in autologous transplantation (en)
page(s)	wds:Q74541729-6762EA88-2579-47CA-8D0B-347D3F29C56B
page(s)	2059-2064
instance of	wds:Q74541729-D38BB5B9-E6A4-460A-AC9F-07C87EE5C0ED
instance of	scholarly article
main subject	wds:Q74541729-0F954C58-473D-480D-A1AC-07DAC42EBA27
main subject	chemotherapy
PubMed ID	wds:Q74541729-ECB98520-8EF8-40AC-AC9B-F2F13D5BD6D3
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/11567990
PubMed ID	11567990
published in	wds:Q74541729-0D0332EA-C3D6-4D91-87FF-84EDD432FA13
published in	Blood
issue	wds:Q74541729-0630B5CC-3B92-412E-8ABF-B691374CBFD5
volume	wds:Q74541729-3EA75F5F-5084-4163-95E4-CAF2D9B09E5D
issue	7
volume	98
DOI	wds:Q74541729-51630DA1-C0AA-44DF-AA47-402655E12464
DOI	http://dx.doi.org/10.1182/BLOOD.V98.7.2059
DOI	10.1182/BLOOD.V98.7.2059
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q74541729
is cites work of	Cyclophosphamide-based hematopoietic stem cell mobilization before autologous stem cell transplantation in newly diagnosed multiple myeloma Outcomes and costs of autologous stem cell mobilization with chemotherapy plus G-CSF vs G-CSF alone Peripheral blood stem cell mobilization by granulocyte colony-stimulating factor alone and engraftment kinetics following autologous transplantation in children and adolescents with solid tumor Improving stem cell mobilization strategies: future directions Canadian supportive care recommendations for the management of neutropenia in patients with cancer Comparison of high-dose CY and growth factor with growth factor alone for mobilization of stem cells for transplantation in patients with multiple myeloma Mobilization, harvesting and selection of peripheral blood stem cells in patients with autoimmune diseases undergoing autologous hematopoietic stem cell transplantation. High-dose cyclophosphamide with or without etoposide for mobilization of peripheral blood progenitor cells in patients with multiple myeloma: efficacy and toxicity Plerixafor for PBSC mobilisation in myeloma patients with advanced renal failure: safety and efficacy data in a series of 21 patients from Europe and the USA. Impact of different strategies of second-line stem cell harvest on the outcome of autologous transplantation in poor peripheral blood stem cell mobilizers The whys and hows of hematopoietic progenitor and stem cell mobilization The role of pegfilgrastim in mobilization of hematopoietic stem cells High-dose versus low-dose cyclophosphamide in combination with G-CSF for peripheral blood progenitor cell mobilization The effect of the dexamethasone, cytarabine, and cisplatin (DHAP) regimen on stem cell mobilization and transplant outcomes of patients with non-Hodgkin's lymphoma who are candidates for up-front autologous stem cell transplantation. G-CSF alone vs cyclophosphamide plus G-CSF in PBPC mobilization of patients with lymphoma: results depend on degree of previous pretreatment Importance of blood graft characteristics in auto-SCT: implications for optimizing mobilization regimens PBSC mobilization in newly diagnosed patients with POEMS syndrome: outcomes and prognostic factors. High-dose ara-C with autologous peripheral blood progenitor cell support induces a marked progenitor cell mobilization: an indication for patients at risk for low mobilization. Factors for PBPC collection efficiency and collection predictors Factors affecting hematopoietic progenitor cell mobilization: an analysis of 307 patients Contaminating tumour cells in autologous PBSC grafts do not influence survival or relapse following transplant for multiple myeloma or B-cell non-Hodgkin's lymphoma Successful CD34+ cell mobilization by intermediate-dose Ara-C in chronic lymphocytic leukemia patients treated with sequential fludarabine and Campath-1H. The influence of parathyroid hormone on the adult hematopoietic stem cell niche. Ancestim (recombinant human stem cell factor, SCF) in association with filgrastim does not enhance chemotherapy and/or growth factor-induced peripheral blood progenitor cell (PBPC) mobilization in patients with a prior insufficient PBPC collection Difficult stem cell mobilization despite adequate CD34+ cell dose predicts shortened progression free and overall survival after autologous HSCT for lymphoma Cyclophosphamide, etoposide and G-CSF to mobilize peripheral blood stem cells for autologous stem cell transplantation in patients with lymphoma Proposed definition of 'poor mobilizer' in lymphoma and multiple myeloma: an analytic hierarchy process by ad hoc working group Gruppo ItalianoTrapianto di Midollo Osseo Effect of prior chemotherapy on hematopoietic stem cell mobilization ESHAP + fixed dose G-CSF as autologous peripheral blood stem cell mobilization regimen in patients with relapsed or refractory diffuse large cell and Hodgkin's lymphoma: a single institution result of 127 patients. Contribution of chemotherapy mobilization to disease control in multiple myeloma treated with autologous hematopoietic cell transplantation. The effect of gradual increment in rhG-CSF dose on stem cell yields in patients with multiple myeloma mobilized with intermediate dose cyclophosphamide plus rhG-CSF. A randomised study comparing peripheral blood progenitor mobilisation using intermediate-dose cyclophosphamide plus lenograstim with lenograstim alone Stem cell mobilization in HIV seropositive patients with lymphoma. EPO in combination with G-CSF improves mobilization effectiveness after chemotherapy with ifosfamide, epirubicin and etoposide and reduces costs during mobilization and transplantation of autologous hematopoietic progenitor cells Bendamustine, etoposide and dexamethasone to mobilize peripheral blood hematopoietic stem cells for autologous transplantation in patients with multiple myeloma Plerixafor in AL amyloidosis: improved graft composition and faster lymphocyte recovery after auto-SCT in patient with end-stage renal-disease Intermediate-dose Ara-C plus G-CSF for stem cell mobilization in patients with lymphoid malignancies, including predicted poor mobilizers Upfront use of plerixafor and granulocyte-colony stimulating factor (GCSF) for stem cell mobilization in patients with multiple myeloma: efficacy and analysis of risk factors associated with poor stem cell collection efficiency Poor mobilizer and its countermeasures

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software